Clinical Trials Directory

Trials / Completed

CompletedNCT03163771

Evaluation of a New Strategy for the Diagnosis of Peroxisomal Diseases

Status
Completed
Phase
Study type
Observational
Enrollment
8 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The principal aim of the study is to avoid the diagnostic wanderings of patients suffering from a peroxisomal disorder. For this purpose, a new diagnostic strategy is proposed. It rests on functional metabolic explorations and gene studies directly connected to a first-line enlarged physico-chemical detection of metabolites from peroxisomal origin in clinically suspect patients.

Conditions

Timeline

Start date
2018-12-18
Primary completion
2022-08-15
Completion
2022-08-15
First posted
2017-05-23
Last updated
2025-12-05

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03163771. Inclusion in this directory is not an endorsement.

Evaluation of a New Strategy for the Diagnosis of Peroxisomal Diseases (NCT03163771) · Clinical Trials Directory